ArticleChinese journal of integrative medicine2026
Development of Core Outcome Set for Integrative Traditional Chinese and Western Medicine Clinical Research in Spinal Metastases (COS-TCM-SM).
Article in Chinese journal of integrative medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo develop a core outcome set (COS) specifically tailored for integrative medicine clinical research in spinal metastases (SM), aiming to standardize efficacy evaluation and enhance consistency in outcome reporting across clinical trials.
methodsThis study adhered to the methodological standards outlined in the COMET Handbook 1.0, the Core Outcome Set-Standards for Development (COS-STAD), and the T/CACM 1339-2020 guidelines for the development of core outcome sets in Chinese medicine (CM) clinical trials. Candidate outcomes were initially identified through a systematic literature review and semi-structured stakeholder interviews. These outcomes were subsequently refined through a 2-round Delphi survey process, followed by final consensus at an online meeting. The development of a COS for the integration of traditional Chinese medicine and Western medicine clinical research in SM (COS-TCM-SM).
resultsFollowing 2 rounds of the Delphi survey involving 62 and 61 stakeholders respectively, 10 outcomes met the inclusion criteria. A final online consensus meeting involving 25 stakeholders finalized the selection and refined 1 outcome domain. The finalized COS-TCM-SM comprises 11 outcomes categorized into 7 domains: survival (overall survival, progression-free survival), neurological function (spinal cord function), pain (pain relief rate), health-related quality of life (self-care ability, activity status, psychological state), radiological outcomes (spinal stability, local tumor control), CM-specific outcome (syndrome differentiation score), and safety events (adverse events and complications).
conclusionsThe COS-TCM-SM provides a consensus-based framework that standardizes outcome measurement for integrative medicine clinical research in SM. By integrating key indicators from both CM (syndrome differentiation) and Western medicine (survival, radiological outcomes), it directly addresses the critical issue of outcome heterogeneity.
Indexed as
Identifiers
41528667What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.